Treatment and evaluation of CLL: A complicated affair

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

In this issue, Eichhorst and colleagues show in a large randomized phase 3 clinical trial that combination therapy using fludarabine and cyclophosphamide is superior to fludarabine alone for younger previously untreated CLL patients. In addition, they found a reduced level of clinical responses when imaging was considered as part of restaging compared with responses defined by recommended NCI standards.

Original languageEnglish (US)
Pages (from-to)848
Number of pages1
JournalBlood
Volume107
Issue number3
DOIs
StatePublished - Feb 1 2006

    Fingerprint

ASJC Scopus subject areas

  • Hematology

Cite this